Literature DB >> 9306670

Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users.

M Rothe1, F Pragst, K Spiegel, T Harrach, K Fischer, J Kunkel.   

Abstract

Hair samples of 20 volunteers of the techno-music scene, who more or less regularly consumed ecstasy tablets and speed and anonymously reported their abuse history, were analyzed in one to seven 3 cm segments for amphetamine (A), methamphetamine (MA), methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), methylenedioxyethamphetamine (MDE) and N-methyl-1-(1,3-benzodioxol-5-yl)-2-butylamine (MBDB) by digestion in 1 M NaOH, subsequent extraction with C18 Bond Elut columns, derivatization with pentafluoropropionyl anhydride and GC/MS-SIM measurements using deuterated standards of A, MA, MDA and MDMA. The concentrations were in the regions 0.1 to 4.8 ng/mg for A (17 samples), 0.05 to 0.89 ng/mg for MDA (16 samples), 0.1 to 8.3 ng/mg for MDMA (16 samples), 0.12 to 15 ng/mg for MDE (13 samples) and 0.21 to 1.3 ng/mg for MBDB (2 samples). MA was not detected. For comparison the frequency and the concentration of these drugs in 124 different ecstasy tablets were determined by HPLC. The drug concentration in the hair segments were compared with the volunteers' reports. Despite the enormous interindividual differences qualitatively an increase of the total concentration of MDA, MDMA and MDE in the proximate 3 cm segments with increasing ecstasy abuse frequency during the last three month before sampling is recognized. In the individual comparison with the chronological consumer reports in most cases a longer interruption or a change of the abuse intensity is not clearly seen at the segment concentrations. As a reason the incorporation of the drugs from sweat into elder hair regions and the slow removal by washing are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306670     DOI: 10.1016/s0379-0738(97)00123-0

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  5 in total

1.  Altered parahippocampal functioning in cannabis users is related to the frequency of use.

Authors:  Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2010-03-19       Impact factor: 4.530

2.  Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration.

Authors:  Allan J Barnes; Michael L Smith; Sherri L Kacinko; Eugene W Schwilke; Edward J Cone; Eric T Moolchan; Marilyn A Huestis
Journal:  Clin Chem       Date:  2007-11-02       Impact factor: 8.327

3.  Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.

Authors:  Benjamin Becker; Daniel Wagner; Philip Koester; Katja Bender; Christoph Kabbasch; Euphrosyne Gouzoulis-Mayfrank; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2012-09-23       Impact factor: 4.530

Review 4.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Chronic administration of amphetamines disturbs development of neural progenitor cells in young adult nonhuman primates.

Authors:  Rahul R Dutta; Michael A Taffe; Chitra D Mandyam
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-03-28       Impact factor: 5.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.